Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SGN-40: Phase IIb start

This quarter, the partners plan to begin an international Phase IIb

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE